Bulletin of the American Physical Society
2023 Annual Meeting of the APS Far West Section
Volume 68, Number 9
Friday–Saturday, October 6–7, 2023; University of California, San Diego, California
Session S05: Materials Synthesis and Characterization
10:30 AM–12:42 PM,
Saturday, October 7, 2023
University of California, San Diego
Room: Mayer 3405
Chair: David Lederman, University of California, Santa Cruz
Abstract: S05.00001 : Proof-of-Concept of Sterilization with a Six Nines Kill Rate (Kill Rate = 99.9999%) versus Disinfection with a Three Nines Kill Rate (Kill Rate = 99.9%) Using Ultra-Violet Irradiation at 260-280 nm Wavelengths (UV-C) Via Low Cost, Low Energy Consumption, Light Emitting Diodes*
10:30 AM–10:42 AM
Presenter:
Viraj Y Amin
(Infinitum BioMed / SiO2 Innovates LLC/ UV One Hygienics Inc.)
Authors:
Viraj Y Amin
(Infinitum BioMed / SiO2 Innovates LLC/ UV One Hygienics Inc.)
Vishesh Y Amin
(Infinitum BioMed / SiO2 Innovates LLC/ UV One Hygienics Inc.)
Ashwin Suresh
(Infinitum BioMed / SiO2 Innovates LLC/ UV One Hygienics Inc.)
Aarush Thinakaran
(Infinitum BioMed/ SiO2 Innovates/ Arizona State U. Physics)
Nimith Gurijala
(Solar GaAs/ SiO2 Innovates/ Arizona State U. Physics)
Shreyash T Prakash
(Infinitum BioMed/ SiO2 Innovates/ Arizona State U. Physics)
Rishabh Sreepathy
(Infinitum BioMed/ SiO2 Innovates/ Arizona State U. Physics)
Srivatsan J Swaminathan
(Infinitum BioMed / SiO2 Innovates LLC/ UV One Hygienics Inc.)
Riley Rane
(Infinitum BioMed / SiO2 Innovates LLC/ UV One Hygienics Inc.)
Dora D Suppes
(Infinitum BioMed LLC/ UV One Hygienics Inc.)
Mark I Russell-Hill
(Infinitum BioMed LLC/ UV One Hygienics Inc.)
Visweshwar G Swaminathan
(Infinitum BioMed / SiO2 Innovates LLC/ UV One Hygienics Inc.)
Rianna N Rane
(Infinitum BioMed/ SiO2 Innovates LLC/ UV One Hygienics Inc.)
Wesley Peng
(Infinitum BioMed / SiO2 Innovates LLC/ UV One Hygienics Inc.)
Nicole Herbots
(Infinitum BioMed/ SiO2 Innovates/ Arizona State U. Physics)
Nithish Prakash
(Infinitum BioMed / SiO2 Innovates LLC/ UV One Hygienics Inc.)
Collaboration:
Infinitum BioMed LLC Business Partnership with SiO2 Innovates LLC and UV One Hygienics Inc.
FDA/CDC accepted sterilization methods are autoclaving, γ-ray Irradiation, and exposure to ethylene oxide gas at 65 C. All are expensive, time-consuming, and hazardous. The FDA criteria for sterilization is a Sterility Assurance Level (SAL) of 10-6, the probability of a single viable micro-organism occurring on an item after sterilization. 10-6 corresponds to eradication of 106 Colony Forming Units (CFUs) or a kill rate of 99.9999% [2].
Our work investigates cheaper, safer, and faster sterilization via UV-C irradiation at 260-280 nm. UV-C breaks amino acid bonds in RNA/DNA, inhibits growth and eradicates pathogen. UV-C has many advantages, including destroying a broad range of pathogens in air without heat.
Kowalski [3-6] and Rheed [7] have shown that UV-C achieves a SAL = 10-3 and can be widely used in water sanitation. However, full sterilization by UV-C to a SAL = 10-6 hasn't been established.
Can 106 CFUs be reproducibly eradicated via UV-C? Can low cost, low energy consumption UVC LED irradiation reliably achieve sterilization at 260-280 nm? Our previous work shows that UV-C LEDs are effective and more reliable than high energy consumption Fluorescent UV tubes [8]. The present study uses 2 parallel sets of calibrated bacterial cultures of 20 million LactoB. A. CFUs and demonstrates a kill rate of six nines (99.9999%) using 6 sets of ten serial dilutions.
*Infinitum BioMed LLC, SiO2 Innovates LLC, and UV One Hygienics Inc. are here gratefully acknowledged.
Follow Us |
Engage
Become an APS Member |
My APS
Renew Membership |
Information for |
About APSThe American Physical Society (APS) is a non-profit membership organization working to advance the knowledge of physics. |
© 2024 American Physical Society
| All rights reserved | Terms of Use
| Contact Us
Headquarters
1 Physics Ellipse, College Park, MD 20740-3844
(301) 209-3200
Editorial Office
100 Motor Pkwy, Suite 110, Hauppauge, NY 11788
(631) 591-4000
Office of Public Affairs
529 14th St NW, Suite 1050, Washington, D.C. 20045-2001
(202) 662-8700